Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study

Key Points

Key points are not available for this paper at this time.

Abstract

The disease burden of CLL decreased in higher SDI countries but increased in lower ones. Strategies for early detection of asymptomatic CLL, development of novel drugs, and measures against attributable factors should be implemented to combat CLL burden.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Ou et al. (Thu,) studied this question.

synapsesocial.com/papers/69d9449e00ab073a27835989 https://doi.org/https://doi.org/10.3389/fonc.2022.840616

Bookmark

View Full Paper